These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 466929)

  • 21. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
    Rane A; Höjer B; Wilson JT
    Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
    Wang RB; Liu LT; Yiu CH; Chang TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of epileptic dogs as an animal model of human epilepsy.
    Löscher W; Schwartz-Porsche D; Frey HH; Schmidt D
    Arzneimittelforschung; 1985; 35(1):82-7. PubMed ID: 4039156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primidone kinetics and analysis of its interactions with the major antiepileptic drugs].
    Ermani M; Giaretta D; Pellegrini A; Chemello R; Testa G
    Riv Neurol; 1983; 53(2):81-93. PubMed ID: 6879058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of felbamate on carbamazepine and its major metabolites.
    Wagner ML; Remmel RP; Graves NM; Leppik IE
    Clin Pharmacol Ther; 1993 May; 53(5):536-43. PubMed ID: 8491065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug interactions during anticonvulsant therapy in childhood: diphenylhydantoin, primidone, phenobarbitone, clonazepam, nitrazepam, carbamazepin and dipropylacetate.
    Windorfer A; Sauer W
    Neuropadiatrie; 1977 Feb; 8(1):29-41. PubMed ID: 321985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between primidone, carbamazepine, and nicotinamide.
    Bourgeois BF; Dodson WE; Ferrendelli JA
    Neurology; 1982 Oct; 32(10):1122-26. PubMed ID: 6214728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of drug combinations between enzyme-inducing first-generation antiepileptic drugs and inducible drugs in patients with epilepsy.
    Zaccara G; Gualdani E; Policardo L; Palumbo P; Francesconi P
    Epilepsy Behav; 2018 Oct; 87():92-95. PubMed ID: 30126756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First HPLC-UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide, 10,11-trans-dihydroxy-10,11-dihydrocarbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma.
    Serralheiro A; Alves G; Fortuna A; Rocha M; Falcão A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():1-9. PubMed ID: 23507454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of phenobarbital on the pharmacokinetics of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Martines C; Fazio A; Trio R; Pisani F; Tomson T
    Ther Drug Monit; 1991 Mar; 13(2):109-12. PubMed ID: 2053116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of carbamazepine in the neonate and in the child.
    Rey E; d'Athis P; de Lauture D; Dulac O; Aicardi J; Olive G
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):90-6. PubMed ID: 422308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide.
    Tomson T; Tybring G; Bertilsson L
    Clin Pharmacol Ther; 1983 Jan; 33(1):58-65. PubMed ID: 6848300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The auto-induction of carbamazepine during long-term therapy.
    Pynnönen S; Frey H; Sillanpää M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):247-52. PubMed ID: 7450925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of carbamazepine in the dog.
    Frey HH; Löscher W
    Arch Int Pharmacodyn Ther; 1980 Feb; 243(2):180-91. PubMed ID: 7377892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine).
    Lindhout D; Höppener RJ; Meinardi H
    Epilepsia; 1984 Feb; 25(1):77-83. PubMed ID: 6692794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
    Perucca E; Johannessen SI
    Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.